医療法人正秋会

高度で適切な最善治療をなるべく早く

  • 医療法人正秋会ホームトップページ
  • 正秋会について
  • 医療機器紹介
  • 診療内容一覧
    • 一般診療
    • 白内障手術
    • 硝子体手術
    • 緑内障手術
    • 斜視手術
    • 眼瞼手術
    • 内服治療
    • 眼底レーザー治療
    • 硝子体注射
    • ボツリヌス療法
      (眼瞼・顔面痙攣に対する治療)
    • テッペーザ
      (活動性甲状腺眼症に対する新治療薬)
    • アイドック
    • オルソケラトロジー
    • ICL/IPCL
    • 多焦点眼内レンズ
    • アドオンレンズ
    • 一般診療
  • ブログ
    • 論文
    • 手術実績
  • 医療関係者の方へ
  • 採用情報(他サイトへ)
  • サイトマップ
グループ施設
  • 今福鶴見みらい眼科皮フ科クリニック本院 〒536-0002
    大阪府大阪市城東区今福東1-14-11
    鶴見メディカルビル6階
  • 川口眼科醫院 〒570-0083
    大阪府守口市京阪本通2-2-4
    イオンタウン守口3階
  • ハナテンミライ眼科 〒538-0044
    大阪府大阪市鶴見区放出東3丁目22-24
    ヴェルデ放出駅前 3F
  • 日帰り手術専門サイト
  • 公式You Tubeチャンネル
  • マンガでわかるICLによる日帰り視力矯正手術
メニューを閉じ、このページのトップへ移動する↑

論文

業績

  • 医療法人正秋会
  • 業績 -  論文
    論文
    手術実績

研究論文

  1. Cystoid macular oedema after flanged intraocular lens scleral fixation using the Yamane technique: a multicentre cohort study.Sci Rep. 2025 Jan 4;15(1):811.
    doi: 10.1038/s41598-025-85370-y.
    PMID: 39755919; PMCID: PMC11700152.
    Ishikawa H, Uchida K, Terasaki H, Sakamoto T, Kakinoki M, Ohji M, Jujo T, Takagi H, Mitamura Y, Yamada Y, Takamura Y, Sugimoto M, Kondo M, Yoshida S, Fukuyama H, Gomi F.
  2. Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy. Jpn J Ophthalmol.2024;68(5):548-555.
    doi:10.1007/s10384-024-01077-z.
    Masuda Y, Ishikawa H, Ishikawa H, et al.
  3. Impact of drainage retinotomy on surgical outcomes of retinal detachment: insights from the Japan-Retinal Detachment Registry.Sci Rep. 2024;14(1):7795.
    Published 2024 Apr 2.
    doi:10.1038/s41598-024-58453-5.
    Fukuyama H, Ishikawa H, Gomi F; Japan-Retinal Detachment Registry Group.
  4. Subtype prevalence and baseline visual acuity by age in Japanese patients with neovascular age-related macular degeneration.Jpn J Ophthalmol. 2023 Mar;67(2):149-155.
    doi: 10.1007/s10384-023-00981-0.
    Epub 2023 Mar 7.
    PMID: 36879074.
    Sawada T, Yasukawa T, Imaizumi H, Matsubara H, Kimura K, Terasaki H, Ishikawa H, Murakami T, Takeuchi M, Mitamura Y, Mizusawa Y, Takamura Y, Murata T, Kogo J, Ohji M.
  5. Risk Factors for Legal Blindness in 237 Japanese Patients with Exogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST.Ocul Immunol Inflamm. 2023 Jan 26:1-9.
    doi: 10.1080/09273948.2023.2165111.
    Epub ahead of print.
    PMID: 36701518.
    Yoshimura A, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, Okamoto F, Sawada T, Ohji M, Kanda T, Takeuchi M, Miki A, Kusuhara S, Ueda T, Ogata N, Sugimoto M, Kondo M, Yoshida S, Ogata T, Kimura K, Mitamura Y, Jujo T, Takagi H, Terasaki H, Sakamoto T, Sugisawa T, Komuku-Yamamoto Y, Gomi F.
  6. Risk Factors for Legal Blindness in 77 Japanese Patients with Endogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST. Ocul Immunol Inflamm. 2023 Sep;31(7):1505-1512.
    doi: 10.1080/09273948.2022.2112237.
    Epub 2022 Aug 25.
    PMID: 36007241.
    Sugisawa T, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, Okamoto F, Sawada T, Ohji M, Kanda T, Takeuchi M, Miki A, Kusuhara S, Ueda T, Ogata N, Sugimoto M, Kondo M, Yoshida S, Ogata T, Kimura K, Mitamura Y, Jujo T, Takagi H, Terasaki H, Sakamoto T, Komuku Y, Gomi F.
  7. Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire survey.Orphanet J Rare Dis. 2022 Aug 20;17(1):319.
    doi: 10.1186/s13023-022-02478-4.
    PMID: 35987635.
    Takano F, Ueda K, Gondefrooij AD, Yamagami A, Ishikawa H, Chuman H, Ishikawa H, Ikeda Y, Sakamoto T, Nakamura M.
  8. Treatment of diabetic macular edema in real-world clinical practice: The effect of aging.J Diabetes Investig. 2022.
    doi: 10.1111/jdi.13801.
    Epub ahead of print.
    PMID: 35389565.
    Kusuhara S, Shimura M, Kitano S, Sugimoto M, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, Kokado M, Kogo J, Sasaki M, Morizane Y, Utsumi T, Kotake O, Koto T, Terasaki H, Hirano T, Ishikawa H, Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi K, Tsujinaka H, Kondo M, Takagi H, Murata T, Sakamoto T; Japan Clinical Retina Study (J-CREST) group.
  9. Trends in the Prevalence and Progression of Diabetic Retinopathy Associated with Hyperglycemic Disorders during Pregnancy in Japan.J Clin Med. 2021; 11(1): 165.
    Sugimoto M, Sampa K, Tsukitome H, Kato K, Matsubara H, Asami S, Sekimoto K, Kitano S, Yoshida S, Takamura Y, Hirano T, Murata T, Shimizu M, Kinoshita T, Kusuhara S, Sawada O, Ohji M, Yoshikawa R, Kimura K, Ishikawa H, Gomi F, Terasaki H, Kondo M, Ikeda T, On Behalf Of The Writing Committee Of Japan-Clinical Retina Study Group J-Crest.
  10. Conventional Trabeculotomy versus Gonioscopy-Assisted Transluminal Trabeculotomy: A Retrospective Cohort Study. J Clin Med. 2021; 11(1): 46.
    Takata M, Ishikawa H, Ikeda T, Gomi F.
  11. Background factors affecting visual acuity at initialvisit in eyes with central retinal vein occlusion: multicenter study in Japan.J Clin Med, 2021, 10(23):5619.
    Kondo M, Noma H, Shimura M, Matsui Y, Saishin Y, Ohji M, Ishikawa H, Gomi F, Iwata K, Yoshida S, Kusuhara S, Hirai H, Ogata N, Hirano T, Murata T, Tsuboi K, Kamei M, Knoshita T, Kuwayama S, Hirano Y, Ohta M, Kimura K, Takayama K, Takeuchi M, Takamura Y, Okamoto F, Mitamura Y, Terasaki H, Sakamoto T.
  12. Clinical Characteristics and Outcomes in 314 Japanese Patients with Bacterial Endophthalmitis: A Multicenter Cohort Study from J-CREST.Pathogens, 2021,10(4):390.
    Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, Okamoto F, Sawada T, Ohji M, Kanda T, Takeuchi M, Miki A, Kusuhara S, Ueda T, Ogata N, Sugimoto M, Kondo M, Yoshida S, Ogata T, Kimura K, Mitamura Y, Jujo T, Takagi H, Terasaki H, Sakamoto T, Sugisawa T, Komuku Y, Gomi F.
  13. Effects of cataract surgery in Japanese patients with neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol, 2021, 259(5): 1145-1151.
    Nishiguchi F, Ishikawa H, Amaki J, Komuku Y, Kimura A, Gomi F.
  14. Ten-year changes in visual acuity at baseline and at 2 years after treatment in a Japanese population with age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol, 2021, 259(5), 1191-1198.
    Sawada T, Yasukawa T, Imaizumi H, Matsubara H, Kimura K, Terasaki H, Ishikawa H, Murakami T, Takeuchi M, Mitamura Y, Yamashita M, Takamura Y, Murata T, Kogo J, Ohji M.
  15. Characteristics of Japanese patients with Leber’s hereditary optic neuropathy and idebenone trial: a prospective, interventional, non‑comparative study.Jpn J Ophthalmol, 2021, 65(1), 133-142.
    Ishikawa H, Masuda Y, Ishikawa H, Shikishima K, Goseki T, Kezuka T, Terao M, Miyazaki A, Matsumoto K, Nishikawa H, Gomi F, Mimura O.
  16. Visual outcomes and mechanism of open globe injuries with no light perception. Ophthalmol Retina, 2021, 5(5), 489-491.
    Morikawa S, Okamoto F, Okamoto Y, Mitamura Y, Ishikawa H, Harimoto K, Ueda T, Sakamoto T, Sugitani K, Sawada O, Mori J, Takamura Y, Oshika T.
  17. Predictive Biomarker for Progression into the Sunset Glow Fundus of Vogt-Koyanagi-Harada Disease, Using Adaptive Binarization of Fundus Photographs.Trans Vis Sci Tech, 2020, 9(11), 10.
    Komuku Y, Ishikawa H, Ide A, Matsuoka T, Fukuyama H, Okadome T, Gomi F.
  18. Comparative analysis of metamorphopsia and aniseikonia after vitrectomy for epiretinal membrane, macular hole, or rhegmatogenous retinal detachment.PLOSONE, 2020, 15(5), e0232758.
    Fukuyama H, Ishikawa H, Komuku Y, Araki T, Kimura N, Gomi F.
  19. Clinical characteristics and visual outcomes of work-related open globe injuries in Japanese patients.Scientific Reports, 2020; 10(1):1208, DOI:10.1038/s41598-020-57568-9.
    Morikawa S, Okamoto F, Okamoto Y, Mitamura Y, Ishikawa H, Harimoto K, Ueda T, Sakamoto T, Sugitani K, Sawada O, Mori J, Takamura Y, Oshika T, Japan-Clinical Research of study group.
  20. Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention from STREAT-DMO study.Br J Ophthalmol, 2020; 0: 1–7.
    doi: 10.1136/bjophthalmol-2019-315726.
    Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, Kokado M, Kogo J, Sasaki M, Morizane Y, Utsumi T, Koto T, Sonoda S, Hirano T, Ishikawa H, Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Sugimoto M, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi K, Tsujinaka H, Kusuhara S, Kondo M, Takagi H, Murata T, Sakamoto T, on behalf of Japan Clinical Retina Study (J- CREST) group.
  21. A novel method for evaluation of ocular torsion angle by optical coherence tomography. Trans Vis Sci Tech, 2020; 9(3): 27.
    Yamadera K, Ishikawa H, Imai A, Okamoto M, Kimura A, Mimura O, Gomi F.
  22. Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment.Jpn J Ophthalmol, 2019, doi.org/10.1007/s10384-019-00705-3.
    Hosotani Y, Yokoi N, Okamoto M, Ishikawa H, Komuro A, Kato H, Mimura O, Gomi F.
  23. Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.PLOSONE, 2019, doi: 10.1371/journal.pone.0226118.
    Maeda Y, Ishikawa H, Nishikawa H, Shimizu M, Kinoshita T, Ogihara R, Kitano S, Yamanaka C, Mitamura Y, Sugimoto M, Kondo M, Takamura Y, Ogata N, Ikeda T, Gomi F.
  24. Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study.Br J Ophthalmol, 2019, doi: 10.1136/bjophthalmol-2019-315199.
    Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, Kokado M, Kogo J, Sasaki M, Morizane Y, Kotake O, Koto T, Sonoda S, Hirano T, Ishikawa H, Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Sugimoto M, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi K, Tsujinaka H, Kusuhara S, Kondo M, Takagi , Murata T, Sakamoto T; Japan Clinical Retina Study (J-CREST) group.
  25. Flanged intraocular lens fixation via 27-gauge trocars using a double-needle technique decreases surgical wounds without losing its therapeutic effect.Acta Ophthalmol, 2019, doi.org/10.1111/aos.14313.
    Ishikawa H, Fukuyama H, Komuku Y, Araki T, Gomi F.
  26. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.Cells, 2019, 8, 1025; doi:10.3390/cells8091025.
    Maeda Y, Nakagomi N, Nakano-Doi A, Ishikawa H, Tatsumi Y, Bando Y, Yoshikawa H, Matsuyama T, Gomi F, Nakagomi T.
  27. Empathy in stroke rats is modulated by social settings. J Cereb Blood Flow Metab, 2019, doi: 10.1177/0271678X19867908.
    Shinozuka K, Tajiri N, Ishikawa H, Tuazon JP, Lee JY, Sanberg PR, Zarriello S, Corey S, Kaneko Y, Borlongan CV.
  28. Tilted disc syndrome associated with serous retinal detachment: long-term prognosis. A retrospective multicenter survey.
    Am J Ophthalmol, 2019, DOI: 10.1016/j.ajo.2019.05.027.
    Kubota F, Suetsugu T, Kato A, Gomi F, Takagi S, Kinoshita T, Ishikawa H, Mitamura Y, Kondo M, Iwahashi C, Kuwayama S, Kurimoto Y, Ogura Y, Yasukawa T, on behalf of the Japanese Clinical Retina Study (J-CREST) Group.
  29. Comparison of US and International Ophthalmic Drug Pricing. Ophthalmology, 2019, 126(10):1358-1365.
    doi: 10.1016/j.ophtha.2019.04.018.
    Gong D, Chang SJ, Barbany M, Corcostegui FB, Değirmenci MFK, Ishikawa H, Mammo Z, Ozmert E, Rossi T, Chang S.
  30. Central serous chorioretinopathy with and without steroids: A multicenter survery. PLOS ONE, 2019;14(2): e0213110.
    Araki T, Ishikawa H, Iwahashi C, Niki M, Mitamura Y, Sugimoto M, Kondo M, Kinoshita T, Nishi T, Ueda T, Kato A, Yasukawa T, Takamura Y, Gomi F.
  31. Quantitative assessment of outer retinal folds on enface optical coherence tomography after vitrectomy for rhegmatogenous retinal detachment. Scientific Reports, 2019; 9:2327.
    Fukuyama H, Yagiri H, Araki T, Iwami H, Yoshida Y, Ishikawa H, Kimura N, Kakusho K, Okadome T, Gomi F.
  32. Scleral Buckling versus Vitrectomy for Young Japanese Patients with Rhegmatogenous Retinal Detachment in the Era of Microincision Surgery: Real-World Evidence from a Multicentre Study in Japan. Acta Ophthalmol, 2019, 97(5): e736-e741.doi.org/10.1111/aos.14050.
    Ingen S; Ishikawa H, Nishikawa H, Morikawa S, Okamoto F, Sakamoto T, Sugimoto M, Kondo M, Iwasaki M, Kinoshita T, Toibana T, Mitamura Y, Takamura Y, Motohashi R, Shimura M, Sakurai Y, Takeuchi M, Gomi F.
  33. Clinical characteristics and outcomes of open globe injuries in Japan. Jpn J Ophthalmol, 2019.
    Okamoto Y, Morikawa S, Okamoto F, Inomoto N, Ishikawa H, Ueda T, Sakamoto T, Sugitani K, Oshika T.
  34. Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan. J Diabetes Investig, 2018.
    Sugimoto M, Tsukitome H, Okamoto F, Oshika T, Ueda T, Niki M, Mitamura Y, Ishikawa H, Gomi F, Kitano S, Noma H, Shimura M, Sonoda S, Sawada O, Ohji M, Harimoto K, Takeuchi M, Takamura Y, Kondo M, Sakamoto T.
  35. Clinical characteristics and outcomes of fall-related open globe injuries in Japan. Graefes Arch Clin Exp Ophthalmol, 2018.
    Morikawa S, Okamoto Y, Okamoto F, Inomoto N, Ishikawa H, Harimoto K, Ueda T, Sakamoto T, Oshika T.
  36. Clinical characteristics and visual outcomes of sport-related open globe injuries. Acta Ophthalmol, 2018.
    Morikawa S, Okamoto F, Okamoto Y, Inomoto N, Ishikawa H, Ueda T, Sakamoto T, Hirano Y, Sawada O, Mori J, Takamura Y, Oshika T.
  37. Indocyanine Green Dye Filling Time for Polypoidal Lesions in Polypoidal Choroidal Vasculopathy Affects the Visibility of the Lesions on OCT Angiography. Ophthalmol-Retina, 2018.
    Fukuyama H, Iwami H, Araki T, Ishikawa H, Ikeda N, Gomi F.
  38. TRAFFIC ACCIDENT-RELATED OPEN GLOBE INJURIES. Retina, 2017.
    Okamoto Y, Morikawa S, Okamoto F, Mitamura Y, Ishikawa H, Ueda T, Sakamoto T, Sugitani K, Sawada O, Mori J, Takamura Y, Oshika T.
  39. Anti-cancer drug Nab-Paclitaxel may exacerbate corneal epithelial disorder. Journal of Clinical Case Reports, 2017.
    Hosotani Y, Ishikawa H, Miyanaga K, Gomi F.
  40. Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice. Scientific Reports, 2017; 7(1):10053.
    Imai Y, Hosotani Y, Ishikawa H, Yasuda K, Nagai M, Jitsukawa O, Gomi F, Nakanishi K, Yoshimoto T, Nakamura T, Yamanishi K.
  41. In toto extraction of spontaneous conjunctival cysts without incision under slit-lamp microscopic view. Canadian Journal of Ophthalmol, 2016; 51(6):423-425.
    Ikeda N, Ikeda T, Ishikawa H.
  42. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm. Japanese Journal of Ophthalmol, 2016; 60(6):486-491.
    Isshiki Y, Ishikawa H, Mimura O.
  43. Retrospective study of recession of four horizontal rectus muscle in periodic alternating nystagmus. Journal of Clinical Ophthalmology, 2014 (8), 2523-2528.
    Mimura O, Ishikawa H, Kimura N, Kimura A, Borlongan CV.
  44. Combination Therapy of Human Umbilical Cord Blood Cells and Granulocyte Colony Stimulating Factor Reduces Histopathological and Motor Impairments in an Experimental Model of Chronic Traumatic Brain Injury. PLOSONE, 2014; 9(3).
    Acosta S, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, Song S, Kaneko Y, Borlongan CV.
  45. Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. Journal of Neuroscience, 2014; 34(1):313-26.
    Tajiri N, Acosta S, Shahaduzzaman MD, Ishikawa H, Shinozuka K, Pabon M, Hernandez-Ontiveros D, Kim D, Metcalf C, Staples M, Dailey T, Vasconcellos J, Franyuti G, Gould L, Patel N, Cooper D, Kaneko Y, Borlongan CV, Bickford P.
  46. Suppressed cytokine expression immediately following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response. Brain Research, 2014; 1559:65-71.
    Tajiri N, Hernandez D, Acosta S, Shinozuka K, Ishikawa H, Ernhart J, Diamandis T, Gonzales-Portillo C, Borlongan MC, Tan J, Kaneko Y, Borlongan CV.
  47. A case with transient refractive change after removal of pituitary tumor. BMC Ophthalmology, 2013 Nov; 13(1):65.
    Ishikawa H, Akura J, Uchida K, Ikeda N, Ikeda T, Borlongan CV, Mimura O.
  48. Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke, 2013; 44(12):3473-81.
    Ishikawa H, Tajiri N, Shinozuka K, Vasconcellos J, Kaneko Y, Lee HJ, Mimura O, Dezawa M, Kim SU, Borlongan CV.
  49. Ischemic stroke brain sends indirect cell death signals to the heart. Stroke, 2013; 44(11):3175-82.
    Ishikawa H, Tajiri N, Vasconcellos J, Kaneko Y, Mimura O, Dezawa M, Borlongan CV.
  50. Stroke in the eye of the beholder. Medical Hypotheses, 2013; 80: 411-415.
    Ishikawa H, Caputo M, Franzese N, Weinbren NL, Slakter A, Patel M, Stahl CE, Jacotte MA, Acosta S, Franyuti G, Shinozuka K, Tajiri N, Loveren HV, Kaneko Y, Borlongan CV.
  51. Stem cell recruitment of newly formed host cells via successful seduction? Filling the gap between neurogenic niche and injured brain site. PLOS ONE, 2013;8(9): e74857.
    Tajiri N, Kaneko Y, Shinozuka K, Ishikawa H, Yankee E, McGrogan M, Case C, Borlongan CV.
  52. Blood-Brain Barrier Alterations Provide Evidence of Subacute Diaschisis in an Ischemic Stroke Rat Model. PLOS ONE, 2013; 8(5): e63553.
    DOI: 10.1371/journal.pone.0063553.
    Garbuzova-Davis S, Rodrigues MCO, Hernandez-Ontiveros DG, Tajiri N, Frisina-Deyo A, Boffeli SM, Abraham JV, Pabon M, Wagner A, Ishikawa H, Shinozuka K, Haller E, Sanberg PR, Kaneko Y, Borlongan CV.
  53. Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLOS ONE, 2013; 8(1): e53376.
    DOI: 10.1371/journal.pone.0053376.
    Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Grimmig B, Diamond D, Sanberg PR, Bickford PC, Kaneko Y, Borlongan CV.
  54. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury. PLOS ONE, 2013; 8(12): e81585.
    Acosta SA, Diamond MD, Wolfe S, Tajiri N, Shinozuka K, Ishikawa H, Hernandez GD, Sanberg PR, Kaneko Y, Borlongan CV.
  55. Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury. Cell Medicine (2012), 4(2), 55-63.
    Kaneko Y, Tajiri N, Yu SJ, Hayashi T, Stahl CE, Bae E, Mestre H, Franzese N, Rodrigues Jr. A, Rodrigues MC, Ishikawa H, Shinozuka K, Hethorn W, Weinbren N, Glover LE, Tan J, Achyuta AH, Loveren HV, Sanberg PR, Shivsankar S, Borlongan CV.
  56. Peripheral nerve regeneration by the in vitro differentiated-human bone marrow stromal cells with Schwann cell property. Biochem Biophys Res Commun (2007), Aug 10; 359(4):915-20.
    Shimizu S, Kitada M, Ishikawa H, Itokazu Y, Wakao S, Dezawa M.
  57. Effects of bone marrow stromal cell injection in an experimental glaucoma model. Biochem Biophys Res Commun (2006), Jun 16; 344(4):1071-9.
    Yu S, Tanabe T, Dezawa M, Ishikawa H, Yoshimura N.
  58. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. SCIENCE (2005), Jul 8; 309(5732):314-7.
    Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, Takeda S, Ide C, Nabeshima Y.
  59. Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens type electrode. Gene Therapy (2005), 12 (4), 289-298.
    Ishikawa H, Takano M, Matsumoto N, Sawada H, Ide C, Mimura O, Dezawa M.
  60. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. Journal of Clinical Investigation (2004) Jun; 113(12): 1701-10.
    Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, Tajima N, Yamada H, Sawada H, Ishikawa H, Mimura T, Kitada M, Suzuki Y, Ide C.
  61. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse.Biochem. Bioph. Res. Co., 2004 Jan 23; 313(4):1015-22.
    Takano Y, Ohguro H, Dezawa M, Ishikawa H, Yamazaki H, Ohguro I, Mamiya K, Metoki T, Ishikawa F, Nakazawa M.

レビュー論文

  1. Stroke and Cardiac cell death: two peas in a pod. Clinical Neurology and Neurosurgery (2016), doi: 10.1016/j.clineuro.2016.01.001.
    Gonzales-Portillo C, Ishikawa H, Shinozuka K, Tajiri N, Kaneko Y, Borlongan CV.
  2. Stem cell-paved biobridge facilitates neural repair in traumatic brain injury. Frontiers in Systems Neuroscience (2014),doi:10.3389/fnsys.2014.00116.
    Tajiri N, Duncan K, Antoine A, Pabon M, Acosta SA, Pena Idl, Hernadez-Ontiveros DG, Shinozuka K, Ishikawa H, Kaneko Y, Yankee E, McGrogan M, Case C, Borlongan CV.
  3. Stem Cell Transplantation for Neuroprotection in Stroke. Brain Sciences (2013), 3(1), 239-261; doi:10.3390/brainsci3010239.
    Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan CV.
  4. Stem cells for neurovascular repair in stroke. Journal of stem cell research & therapy (2013), 4(4):12912.
    Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kim DW, Pabon M, Acosta SA, Kaneko Y, Borlongan CV.
  5. A Step-Up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells. Translational Stroke Research (2012), Mar; 3(1): 90-98.
    Glover LE, Tajiri N, Weinbren NL, Ishikawa H, Shinozuka K, Kaneko Y, Borlongan CV.
  6. Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke.J Biomed Biotechnol (2011), Vol 2011: 194720.
    Rodrigues MCO, Glover LE, Weinbren NL, Rizzi JA, Ishikawa H, Shinozuka K, Tajiri N, Kaneko Y, Sanberg PR, Allickson JG, Kuzmin-Nichols N, Garbuzova-Davis S, Borlongan CV.
医療法人正秋会

高度で適切な最善治療をなるべく早く

  • 医療法人正秋会ホームトップページ
  • 正秋会について
  • 医療機器紹介
  • 診療内容一覧
    • 一般診療
    • 白内障手術
    • 硝子体手術
    • 緑内障手術
    • 斜視手術
    • 眼瞼手術
    • 内服治療
    • 眼底レーザー治療
    • 硝子体注射
    • ボツリヌス療法
      (眼瞼・顔面痙攣に対する治療)
    • テッペーザ
      (活動性甲状腺眼症に対する新治療薬)
    • アイドック
    • オルソケラトロジー
    • ICL/IPCL
    • 多焦点眼内レンズ
    • アドオンレンズ
    • 一般診療
  • ブログ
    • 論文
    • 手術実績
  • 医療関係者の方へ
  • 採用情報(他サイトへ)
  • サイトマップ
グループ施設
  • 今福鶴見みらい眼科皮フ科クリニック本院 〒536-0002
    大阪府大阪市城東区今福東1-14-11
    鶴見メディカルビル6階
  • 川口眼科醫院 〒570-0083
    大阪府守口市京阪本通2-2-4
    イオンタウン守口3階
  • ハナテンミライ眼科 〒538-0044
    大阪府大阪市鶴見区放出東3丁目22-24
    ヴェルデ放出駅前 3F
  • 日帰り手術専門サイト
  • 公式You Tubeチャンネル
  • マンガでわかるICLによる日帰り視力矯正手術
BACK TO TOP サイトマップ

©医療法人正秋会